Prognostic Significance of Subtype Classification for Short- and Long-Term Survival in Breast Cancer: Survival Time Holds the Key

1. BerryDA

CirrincioneC

HendersonIC

CitronML

BudmanDR

GoldsteinLJ

MartinoS

PerezEA

MussHB

NortonL

HudisC

WinerEP

2006 Estrogen-receptor status and outcomes of modern chemotherapy for patients with node-positive breast cancer. JAMA 295 1658 1667

2. JatoiI

ChenBE

AndersonWF

RosenbergPS

2007 Breast cancer mortality trends in the United States according to estrogen receptor status and age at diagnosis. J Clin Oncol 25 1683 1690

3. NewmanLA

GriffithKA

JatoiI

SimonMS

CroweJP

ColditzGA

2006 Meta-analysis of survival in African American and white American patients with breast cancer: ethnicity compared with socioeconomic status. J Clin Oncol 24 1342 1349

4. CareyLA

PerouCM

LivasyCA

DresslerLG

CowanD

ConwayK

KaracaG

TroesterMA

TseCK

EdmistonS

DemingSL

GeradtsJ

CheangMC

NielsenTO

MoormanPG

EarpHS

MillikanRC

2006 Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA 295 2492 2502

5. JemalA

SiegelR

WardE

HaoY

XuJ

ThunMJ

2009 Cancer statistics, 2009. CA Cancer J Clin 59 225 249

6. BlowsFM

DriverKE

SchmidtMK

BroeksA

van LeeuwenFE

2010 Subtyping of Breast Cancer by Immunohistochemistry to Investigate a Relationship between Subtype and Short- and Long-Term Survival: A Collaborative Analysis of Data for 10,159 Cases from 12 Studies. PLoS Med 7(5) e1000279

7. PerouCM

SorlieT

EisenMB

Van DeRM

JeffreySS

ReesCA

PollackJR

RossDT

JohnsenH

AkslenLA

FlugeO

PergamenschikovA

WilliamsC

ZhuSX

LonningPE

Borresen-DaleAL

BrownPO

BotsteinD

2000 Molecular portraits of human breast tumours. Nature 406 747 752

8. SorlieT

PerouCM

TibshiraniR

AasT

GeislerS

JohnsenH

HastieT

EisenMB

Van DeRM

JeffreySS

ThorsenT

QuistH

MateseJC

BrownPO

BotsteinD

EysteinLP

Borresen-DaleAL

2001 Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A 98 10869 10874

9. NalwogaH

ArnesJB

WabingaH

AkslenLA

2010 Expression of aldehyde dehydrogenase 1 (ALDH1) is associated with basal-like markers and features of aggressive tumours in African breast cancer. Br J Cancer 102 369 375

10. NielsenTO

HsuFD

JensenK

CheangM

KaracaG

HuZ

Hernandez-BoussardT

LivasyC

CowanD

DresslerL

AkslenLA

RagazJ

GownAM

GilksCB

Van DeRM

PerouCM

2004 Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma. Clin Cancer Res 10 5367 5374

11. MulliganAM

PinnaduwageD

BullSB

O'MalleyFP

AndrulisIL

2008 Prognostic effect of basal-like breast cancers is time dependent: evidence from tissue microarray studies on a lymph node-negative cohort. Clin Cancer Res 14 4168 4174

12. RouzierR

PerouCM

SymmansWF

IbrahimN

CristofanilliM

AndersonK

HessKR

StecJ

AyersM

WagnerP

MorandiP

FanC

RabiulI

RossJS

HortobagyiGN

PusztaiL

2005 Breast cancer molecular subtypes respond differently to preoperative chemotherapy. Clin Cancer Res 11 5678 5685

13. CareyLA

DeesEC

SawyerL

GattiL

MooreDT

CollichioF

OllilaDW

SartorCI

GrahamML

PerouCM

2007 The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes. Clin Cancer Res 13 2329 2334

14. FanC

OhDS

WesselsL

WeigeltB

NuytenDS

NobelAB

Van't VeerLJ

PerouCM

2006 Concordance among gene-expression-based predictors for breast cancer. N Engl J Med 355 560 569

15. Van de VijverMJ

HeYD

Van't VeerLJ

DaiH

HartAA

VoskuilDW

SchreiberGJ

PeterseJL

RobertsC

MartonMJ

ParrishM

AtsmaD

WitteveenA

GlasA

DelahayeL

van dV

BartelinkH

RodenhuisS

RutgersET

FriendSH

BernardsR

2002 A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 347 1999 2009

16. CleatorS

HellerW

CoombesRC

2007 Triple-negative breast cancer: therapeutic options. Lancet Oncol 8 235 244